New treatment for Retinitis Pigmentosa (n. 143)

Field of use

Ophthalmology

inizio pagina


Description

The invention relates to the new use of known inhibitors which have shown an antiapoptotic activity, thus delaying inherited retinal degenerations. The patent application also claims an innovative administration system. The invention is supported by an initial in vivo validation.

inizio pagina


Advantages

For the first time the disease is cured hitting a pathway that is usually turned on during the degeneration of the photoreceptors typical of the Retinitis. Moreover, the molecule used is natural and with a good solubility rate and it has not shown any toxic effect on normal cells.

inizio pagina


Suggested applications

Prevention and cure of Retinitis Pigmentosa

inizio pagina


Inventors

Riccardo Ghidoni
Enrica Strettoi
Maria Claudia Gargini
Paolo Gasco

inizio pagina


Applicants

Università degli Studi di Milano
Consiglio Nazionale delle Ricerche
Università degli Studi di Pisa
Nanovecotor s.r.l.

inizio pagina


Legal status

Granted patent in USA, Europe and China
National Application in Canada, Japan

inizio pagina


Contacts

For technical and scientific information:
Prof. Riccardo Ghidoni
Dipartimento di Medicina, Chirurgia e Odontoiatria
riccardo.ghidoni@unimi.it

inizio pagina